Co-Authors
This is a "connection" page, showing publications co-authored by Andrea Cossarizza and Stefano Busani.
Connection Strength
0.974
-
Two Fatal Cases of Acute Liver Failure Due to HSV-1 Infection in COVID-19 Patients Following Immunomodulatory Therapies. Clin Infect Dis. 2021 07 01; 73(1):e252-e255.
Score: 0.238
-
Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia. EMBO Mol Med. 2020 12 07; 12(12):e13001.
Score: 0.228
-
Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia. Ther Adv Respir Dis. 2020 Jan-Dec; 14:1753466620951043.
Score: 0.215
-
The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study. PLoS One. 2021; 16(8):e0251378.
Score: 0.060
-
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients. Sci Rep. 2021 06 16; 11(1):12716.
Score: 0.059
-
Methylprednisolone as rescue therapy after tocilizumab failure in patients with severe COVID-19 pneumonia. Clin Exp Rheumatol. 2021 Sep-Oct; 39(5):1141.
Score: 0.058
-
Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV-2 infection: retrospective cohort study. Multidiscip Respir Med. 2021 Jan 15; 16(1):737.
Score: 0.058
-
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia-Challenges, strengths, and opportunities in a global health emergency. PLoS One. 2020; 15(11):e0239172.
Score: 0.057